Exploratory Clinical Trials of ACM-1 in the Treatment of Ophthalmological Neovascular Diseases
Status:
Unknown status
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the role of intravitreal injection of
anti-vascular endothelial growth factor (VEGF) therapy in prevention and control of
ophthalmological neovascular diseases, in order to find a new strategy of treatment for
ophthalmological neovascular diseases